Article

Coalition Offers Broad Framework to Improve Kidney Care

A coalition of patient advocates, dialysis-care providers and manufacturers today will unveil a comprehensive new framework for kidney care across the country that identifies four goals: improve survival, reduce hospitalizations, improve health-related quality of life, and improve patient experience with care.

A coalition of patient advocates, dialysis-care providers and manufacturers today will unveil a comprehensive new framework for kidney care across the country that identifies four goals: improve survival, reduce hospitalizations, improve health-related quality of life, and improve patient experience with care.

Kidney Care Partners—established in 2003 to improve care for people with chronic kidney disease—will release A Strategic Blueprint for Advancing Kidney Care Quality (PDF), after more than a year of work on the ambitious plan. The blueprint will also be the focus of a webinar on world kidney day on March 13.

The blueprint cites data from the U.S. Renal Data System that roughly 615,000 adults and about 9,000 children lived with end-stage renal disease in 2011 and required either dialysis or a transplant to survive. While there have been recent improvements in kidney care, members of Kidney Care Partners thought more needed to be done. At a meeting roughly two years ago, members discussed ways to drive quality in this segment and determined they needed to step back and establish priorities.

Read the full story here: http://bit.ly/1fCi1OL

Source: Modern Healthcare

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
4 KOLs are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo